FIIND Lab

Active Studies:

1. AWARE: Autism with ADHD Research on Effectiveness
2. Clinical translation of a genetic diagnosis for mental health in autism (with the POND network)
3. The RADAR study: RAre Disease Administrative Data Research (RADAR) Team: Putting the Health System Impact of Rare Diseases on the Radar
4. Psychopharmacology in children with neurodevelopmental differences and disabilities: trajectories and subgroup analysis predicting response and tolerability
5. Fluoxetine for Developmental and Neurologic Outcomes in KCNC1-Related Disorder: a single subject trial

Meet the staff and students

Scientist

Dr. Danielle Baribeau is a child and adolescent psychiatrist with a clinical focus in autism, genetic neurodevelopmental disorders, and psychopharmacology. She completed her PhD in clinical epidemiology and health-care research at the University of Toronto (U of T) in 2022, which focused on understanding anxiety in autism. She completed her clinical residency training in adult psychiatry, and then child and adolescent psychiatry, at U of T in 2019.  This was followed by a two-year fellowship at SickKids in consultation-liaison psychiatry, neurodevelopmental assessment, and rare neurogenetic conditions associated with psychiatric and neurodevelopmental outcomes. She has also worked clinically at Holland Bloorview since 2020.

As a clinician scientist at the Bloorview Research Institute, she leads a research program focused on clinically translating genetic advances into improved mental health care in autism and neurodevelopmental disorders.   Dr. Baribeau also works as a child psychiatrist at Holland Bloorview’s Child Development program’s Psychopharmacology Clinic and the Autism Communication, Learning and Behaviour program.

Links:

• Please click here to learn more about Dr. Danielle Baribeau’s education background and more.
• Danielle Baribeau, Assistant Professor, University of Toronto, Temerity Faculty of Medicine

Research Staff

• Jesiqua Rapley, Research Coordinator
• Lily He, Research Coordinator
• Christina Tsetsos, Research Coordinator
• Haochen Yu, Research Assistant
• Catherine Petta, Research Nurse

Current Trainees

• Sophia Lenz, MASc Candidate
• Vedika Jha, GDipHR Student
• Ajilan Sivaloganathan, Medical Student
• Navya Vyas, Undergraduate Thesis Student

Past Trainees

• Avery Longmore, Pediatrics Resident
• Emma Canning, Summer Student
• Sajeela Rana, Summer Student

Below are some of our publications.

Find more of our published work with Dr. Baribeau on Google Scholar

• Summers, J., Baribeau, D., Perlman, P., Hoang, N., Cui, S., Krakowski, A., Ambrozewicz, P., Ho, A., Selvanayagam, T., Sandor-Bajusz, K., Patel, N., McGaughey, S., Gallagher, L., Scherer, S., Szatmari, P., Vorstman, J. - 2025 - An integrated clinical approach to children at risk for neurodevelopmental and psychiatric conditions: interdisciplinary collaboration and research infrastructure. Journal of Neurodevelopmental Disorders.
• Longmore, A., Anagnostou, E., Georgiages, S., Jones, J., Kelley, E., Baribeau, D. - 2024 - Predictors of Depressive Symptoms in Autistic Youth – A Longitudinal Study from the Province of Ontario Neurodevelopmental Disorders (POND) Network. Canadian Journal of Psychiatry.
• Baribeau, D., Vorstman, J., Pearson, T. - 2024 - Selective serotonin reuptake inhibitor treatment post gene therapy for an ultrarare neurometabolic disorder (AADC deficiency). Journal of the American Academy of Child & Adolescent Psychiatry.
• AlMail, A., Jamjoom, A., Pan, A., ... IPCHiP Executive Committee, Bassett, A., Christodoulou, J., Dupuis, L., Gill, P., Levy, T., Siper, P., Stark, Vorstman, J., Diskin, C., Jewitt, N., Baribeau, D., Costain, G. - 2024 - Gaps in the phenotype descriptions of ultra-rare genetic conditions: review and multi-center consensus reporting guidelines. npj Genomic Medicine.
• Baribeau, D., Arneja, J., Wang, X., Howe, J., McLaughlin, J., Tu, K., Guan, J., Iaboni, A., Kelley, E., Ayub, M., Nicolson, R., Georgiades, R., Scherer, S., Bronskill, S., Anagnostou, E., Brooks, J. – 2023 - Short report: Linkage of whole genome sequencing and administrative health data in autism: A proof of concept study.Autism Research.
• Perlman, P., Vorstman, J., Baribeau, D., Hoang, N., Summers, J., Cunningham, J., Mulsant, B. – 2023 - Support to caregivers who have received genetic information about neurodevelopmental and psychiatric vulnerability in their young children: a narrative review. Clinical Genetics.
• Kaster, T.S., Downar, J., Vila-Rodriguez, F., Baribeau, D.A., Thorpe, K.E., Daskalakis, Z.J., Blumberger, D.M. – 2023 - Differential symptom cluster responses to repetitive transcranial magnetic stimulation treatment in depression. eClinicalMedicine.
• Baribeau, D.A., Hoang, N., Selvanayagam, T, Stavropoulos, D.J., Costain, G., Scherer, S.W., Vorstman, J. - 2022 - Developmental Implications from Genetic Testing for Physical Indications. European Journal of Human Genetics.
• Baribeau, D.A., Vigod, S., Pullenayegum, E., Kerns, C., Mirenda, P., Smith, I., . . . Szatmari, P. – 2022 - Developmental Cascades Between Anxiety and Insistence on Sameness Behaviour in Autism Spectrum Disorder. European Journal of Child and Adolescent Psychiatry.
• Baribeau, D.A., Vigod, S., Brittain, H., Vaillancourt, T., Szatmari, P., Pullenayegum, E. – 2022 - Application of Transactional (Cross-lagged) Models in Mental Health Research: An Introduction and Review of Methodological Considerations. Journal of the Canadian Academy of Child and Adolescent Psychiatry.
• Baribeau, D., Vorstman, J., Anagnostou, E. – 2022 - Novel Treatments in Autism Spectrum Disorder. Current Opinion in Psychiatry.

Project: RAre Disease Administrative Data Research (RADAR) Team: Putting the Health System Impact of Rare Diseases on the Radar

Researchers: D. Marshall, D. Baribeau, F. Bernier, I. Stedman, and collaborators

Agency: Canadian Institutes of Health Research (2024-2028)

Project: Fluoxetine for Developmental and Neurologic Outcomes in KCNC1-Related Disorder: a Randomized Within-Subject Multiple Baseline Clinical Trial

Researchers: D. Baribeau and collaborators

Agency: Canadian Institutes of Health Research and Canadian Neurodevelopmental Research Training Platform (CanNRT) (2025–2026)

Project: Clinical Translation of a Genetic Diagnosis for Mental Health in Autism: Linking Genome Sequencing Data to Health Administrative Data

Researchers: D. Baribeau, N. Saunders and collaborators

Agency: Canadian Institutes of Health Research (2024-2027)

Project: RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network

Researchers: T. Lacaze-Masmonteil (PI) and co-investigator team

Agency: Canadian Institutes of Health Research (2024-2029)

Researchers: D. Baribeau (PI)

Agency: CIHR Glenda M. MacQueen Memorial Career Development Award: CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) and the Canadian Psychiatric Association (CPA) (2023)

Project: The AWARE Study: Efficacy of Pharmacologic Management of ADHD in Children and Youth with Autism Spectrum Disorder

Researchers: D. Coury (PI), D. Baribeau (PI: Site), and co-investigator team

Agency: Patient Centered Outcomes Research Institute and Autism Care Network Grant (2023-2027)

Project: Clinical Translation of a Genetic Diagnosis for Mental Health in Autism: Linking genome sequencing and health administrative data.

Researchers: D. Baribeau and co-investigator team

Agency: McLaughlin Centre Special Research Grant (2023–2024

Project: The Province of Ontario Neurodevelopmental Disorders Network

Researchers: E. Anagnostou (PI), J. Lerch (PI), and co-investigator team

Agency: Ontario Brain Institute Integrated Discovery Program (2023–2026)